Prescription Drug News and Research

RSS

Exelixis announces interim data from cabozantinib phase 2 trial on metastatic CRPC

Exelixis, Inc. today announced interim data from 51 patients with metastatic castration-resistant prostate cancer (CRPC) and bone metastases receiving a 40 mg daily dose of cabozantinib in an ongoing non-randomized expansion (NRE) cohort of a phase 2 randomized discontinuation trial.

1 Oct 2012

Exelix reports preliminary data from cabozantinib phase 1 study on solid tumors

Exelixis, Inc. today reported preliminary data from an ongoing phase 1 dose escalation study of cabozantinib in Japan.

1 Oct 2012

Issa threatens to subpoena HHS documents related to Medicare Advantage bonuses

Rep. Darrell Issa, R-Calif., chairman of the House Oversight and Government Reform Committee, alleges that the Department of Health and Human Services is using an $8 billion Medicare bonus payment demonstration project to mask the health law's cuts to Medicare Advantage plans in advance of the election.

29 Sep 2012

A.P. Pharma resubmits APF530 NDA with FDA for prevention of CINV

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead product candidate, APF530, for the prevention of acute- and delayed-onset chemotherapy-induced nausea and vomiting (CINV).

29 Sep 2012

Extend Health announces availability of two free guides for seniors

Extend Health, operator of the nation's largest private Medicare exchange and a Towers Watson company, announced today the availability of two free guides designed to help seniors who are turning 65 - and becoming eligible for Medicare for the first time - navigate the complexity of their health care options to make informed choices about Medicare coverage.

28 Sep 2012

Bayer HealthCare receives FDA approval for Stivarga to treat colorectal cancer

The U.S. Food and Drug Administration today approved Stivarga (regorafenib) to treat patients with colorectal cancer that has progressed after treatment and spread to other parts of the body (metastatic).

28 Sep 2012

Pfizer, Bristol-Myers Squibb report FDA acknowledgement of ELIQUIS NDA resubmission

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the New Drug Application (NDA) resubmission for ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF).

27 Sep 2012

Double-digit premium increases seen in popular Medicare drug plans

Seniors in seven of the 10 most popular Medicare drug plans will see marked premium increases for 2013 if they don't opt to change plans, according to an analysis by Avalere Health.

26 Sep 2012

Prescription drug abuse among young adults drops

Prescription drug abuse by young adults dropped 14 percent last year to its lowest rate since 2002 as authorities continue new attempts to curtail abuse.

26 Sep 2012

First Edition: September 25, 2012

Today's headlines headlines include reports about a study that details accelerating health care spending.

25 Sep 2012

Smoking, obesity and lack of insurance may be shortening life span for some Americans

The New York Times reports that the nation's life-expectancy trend has reversed by four years since 1990 for the country's least-educated whites.

21 Sep 2012

Targeting companies that cut health care costs

Reuters reports that the health care sector will be "a focal point" for years to come and looks at investments in companies that are likely to make money by helping to reduce costs. Meanwhile, Kaiser Health News examines whether competitive health care models like Medicare Part D and the Federal Employees Health Benefits program are taming costs as effectively as supporters suggest.

21 Sep 2012

Many states do not fully analyze data on fatal prescription painkiller overdoses

Prescription painkillers are responsible for more fatal overdoses in the United States than heroin and cocaine combined. And while most states have programs to curb abuse and addiction, a new report from Brandeis University shows that many states do not fully analyze the data they collect.

21 Sep 2012

Administration: Health law led Medicare beneficiaries to save $4.5 billion on prescriptions

USA Today reports the Obama administration is annoucing that, because of provisions in the health law Medicare's prescription drug doughnut hole, Medicare beneficiaries experienced considerable savings.

21 Sep 2012

First Edition: September 21, 2012

Today's headlines include reports about recent polling results indicating that, despite GOP presidential hopeful Mitt Romney's efforts to frame the Medicare debate, President Barack Obama still has the advantage on this issue.

21 Sep 2012

Viewpoints: Romney's comments point to entitlements' role as big part of 'budget paralysis;' Kristof says candidate inflated 'underlying truth'

Stigmatizing almost everyone with a federal benefit is not just bad politics. It's the worst sort of social stereotyping. But beyond (GOP presidential candidate Mitt) Romney's bluster lies a genuine problem.

21 Sep 2012

FDA Oncologic Drugs Advisory Committee to review Celgene’s pomalidomide NDA on Nov. 8

Celgene Corporation today announced the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee will hold a review of the Company's new drug application (NDA) for pomalidomide at its meeting on November 8, 2012.

20 Sep 2012

FDA warns consumers not to use Intestinomicina for treatment of infectious diarrhea

The U.S. Food and Drug Administration is warning consumers not to use Intestinomicina, a drug product manufactured in El Salvador and marketed as a treatment for infectious diarrhea and acute gastrointestinal infections.

19 Sep 2012

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Pfizer Inc. announced today that 14 abstracts for tofacitinib, an investigational oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA), will be presented at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2012 Annual Meeting, which is being held November 9-14 in Washington, D.C.

18 Sep 2012

Roundup: Calif. to probe hospital/doctor consolidations; Cuccinelli warns Va. health board on abortion clinic rules

California's attorney general has launched a broad investigation into whether growing consolidation among hospitals and doctor groups is pushing up the price of medical care, reflecting increasing scrutiny by antitrust regulators of medical-provider deals.

15 Sep 2012

Prescription Drug News and Research

Exelixis announces interim data from cabozantinib phase 2 trial on metastatic CRPC

Exelix reports preliminary data from cabozantinib phase 1 study on solid tumors

Issa threatens to subpoena HHS documents related to Medicare Advantage bonuses

A.P. Pharma resubmits APF530 NDA with FDA for prevention of CINV

Extend Health announces availability of two free guides for seniors

Bayer HealthCare receives FDA approval for Stivarga to treat colorectal cancer

Pfizer, Bristol-Myers Squibb report FDA acknowledgement of ELIQUIS NDA resubmission

Double-digit premium increases seen in popular Medicare drug plans

Prescription drug abuse among young adults drops

First Edition: September 25, 2012

Smoking, obesity and lack of insurance may be shortening life span for some Americans

Targeting companies that cut health care costs

Many states do not fully analyze data on fatal prescription painkiller overdoses

Administration: Health law led Medicare beneficiaries to save $4.5 billion on prescriptions

First Edition: September 21, 2012

Viewpoints: Romney's comments point to entitlements' role as big part of 'budget paralysis;' Kristof says candidate inflated 'underlying truth'

FDA Oncologic Drugs Advisory Committee to review Celgene’s pomalidomide NDA on Nov. 8

FDA warns consumers not to use Intestinomicina for treatment of infectious diarrhea

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Roundup: Calif. to probe hospital/doctor consolidations; Cuccinelli warns Va. health board on abortion clinic rules

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News